Chimera (CIM) CFO receives 54,537 RSUs, boosting stake to 247,826 shares

Rhea-AI Filing Summary

Chimera Investment Corporation’s Chief Financial Officer, Viswanathan Subramaniam, reported an equity award tied to the company’s common stock. On January 20, 2026 he was granted 54,537 restricted stock units (RSUs), each economically equivalent to one share of Chimera common stock and reported at a transaction price of $0, reflecting the nature of the award rather than a market purchase.

The RSUs are scheduled to vest in three equal installments on December 31 of 2026, 2027 and 2028, and will be settled entirely in Chimera common shares. Following this grant, the reporting person beneficially owned 247,826 shares of Chimera common stock on a direct basis, a figure that also includes dividend equivalent rights, which are treated as the economic equivalent of additional shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Viswanathan Subramaniam

(Last) (First) (Middle)

C/O: CHIMERA INVESTMENT CORPORATION

630 FIFTH AVENUE, SUITE 2400

(Street)

NEW YORK NY 10111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CHIMERA INVESTMENT CORP [ CIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/20/2026		A		54,537(1)	A	$0(2)	247,826(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Chimera Investment Corporation ("Chimera") common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on December 31st of 2026, 2027 and 2028 and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

2. Each RSU is the economic equivalent of one share of Chimera common stock.

3. Dividend equivalent rights ("DERs") issued on RSUs and underlying performance stock units or PSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Remarks:

	/s/ Subramaniam Viswanathan	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Chimera Investment Corp (CIM) report?

Chimera Investment Corp reported that its Chief Financial Officer, Viswanathan Subramaniam, received an award linked to common stock on January 20, 2026, consisting of 54,537 restricted stock units (RSUs) with a reported transaction price of $0 per unit.

How many Chimera Investment Corp (CIM) shares were granted to the CFO?

The CFO received 54,537 restricted stock units, each economically equivalent to one share of Chimera Investment Corporation common stock, bringing his total directly held beneficial ownership to 247,826 shares after the grant.

How do the RSUs granted to Chimera’s CFO (CIM) vest?

The restricted stock units granted to the CFO are scheduled to vest in three equal installments, with one-third vesting on December 31, 2026, one-third on December 31, 2027, and the final third on December 31, 2028, and will be settled entirely in Chimera common stock.

What is the economic value relationship between the RSUs and Chimera (CIM) common stock?

Each restricted stock unit granted to the CFO is described as the economic equivalent of one share of Chimera Investment Corporation common stock, meaning each RSU is intended to mirror the value of a single common share.

What are dividend equivalent rights (DERs) mentioned in the Chimera (CIM) insider filing?

Dividend equivalent rights, or DERs, are issued on RSUs and underlying performance stock units. They are included in the reporting person’s common stock holding balance and each DER is stated to be the economic equivalent of one share of Chimera common stock.

Does the Chimera (CIM) CFO plan to report future vesting of these RSUs?

The filing states that the reporting person does not intend to report the vesting of the RSUs or the delivery of the underlying shares of common stock, even though the RSUs will vest annually from 2026 through 2028.